These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31680136)

  • 21. Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study.
    Farooqi J; Niamatullah H; Irfan S; Zafar A; Malik F; Jabeen K
    Clin Microbiol Infect; 2021 Oct; 27(10):1519.e1-1519.e5. PubMed ID: 34111581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.
    Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D
    Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.
    Mikulska M; Giacobbe DR; Furfaro E; Mesini A; Marchese A; Del Bono V; Viscoli C
    Clin Microbiol Infect; 2016 Jul; 22(7):646.e5-8. PubMed ID: 27256062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
    Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study.
    Muñoz P; Vena A; Machado M; Martínez-Jiménez MC; Gioia F; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv13-iv19. PubMed ID: 29608752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological biomarkers of candidemia: a retrospective evaluation of three assays.
    Dichtl K; Seybold U; Wagener J
    Infection; 2019 Apr; 47(2):217-224. PubMed ID: 30264200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients.
    Liu Y; Chen F; Zhu X; Shen L; Zhang SX
    J Clin Microbiol; 2015 Sep; 53(9):3017-20. PubMed ID: 26109441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
    Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
    Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients.
    Murri R; Camici M; Posteraro B; Giovannenze F; Taccari F; Ventura G; Scoppettuolo G; Sanguinetti M; Cauda R; Fantoni M
    Infect Drug Resist; 2019; 12():19-24. PubMed ID: 30588044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
    Guo J; Wu Y; Lai W; Lu W; Mu X
    BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
    Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
    Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early treatment of candidemia in adults: a review.
    Ostrosky-Zeichner L; Kullberg BJ; Bow EJ; Hadley S; León C; Nucci M; Patterson TF; Perfect JR
    Med Mycol; 2011 Feb; 49(2):113-20. PubMed ID: 20818922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
    Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
    Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
    Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
    Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia.
    Giacobbe DR; Berruti M; Mikulska M
    Clin Infect Dis; 2020 Aug; 71(4):1124-1126. PubMed ID: 31665246
    [No Abstract]   [Full Text] [Related]  

  • 37. (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
    Bloos F; Held J; Kluge S; Simon P; Kogelmann K; de Heer G; Kuhn SO; Jarczak D; Motsch J; Hempel G; Weiler N; Weyland A; Drüner M; Gründling M; Meybohm P; Richter D; Jaschinski U; Moerer O; Günther U; Schädler D; Weiss R; Putensen C; Castellanos I; Kurzai O; Schlattmann P; Cornely OA; Bauer M; Thomas-Rüddel D;
    Intensive Care Med; 2022 Jul; 48(7):865-875. PubMed ID: 35708758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation.
    McKeating C; White PL; Posso R; Palmer M; Johnson E; McMullan R
    J Clin Pathol; 2018 May; 71(5):420-424. PubMed ID: 28970296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
    White PL; Posso R; Parr C; Price JS; Finkelman M; Barnes RA
    Clin Infect Dis; 2021 Oct; 73(7):e1415-e1422. PubMed ID: 32914187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.
    Montagna MT; Coretti C; Lovero G; De Giglio O; Montagna O; Laforgia N; Santoro N; Caggiano G
    Int J Mol Sci; 2011; 12(9):5871-7. PubMed ID: 22016633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.